Skip to main content
. 2022 Sep 19;62(4):1621–1626. doi: 10.1093/rheumatology/keac534

Table 2.

Pregnancy outcomes stratified by vaccination status in women with RMDs and COVID-19 results reported as % (n)

Vaccination status Partially or unvaccinateda Fully vaccinatedb P-value
Number of pregnancies 47 26
Pregnancy outcome
Pregnancy ongoing 6.4% (3) 57.7% (15)
Completed pregnancies 93.6% (44) 42.3% (11)
Livebirthsc 93.2% (41) 81.8% (9) 0.26
Term birthc 63.6% (28) 72.7% (8) 0.57
Preterm birthc 29.5% (13) 18.2% (2) 0.45
Miscarriage 2.1% (1) 0 0.80
Termination 0 3.8% (1) 0.20
Stillbirth 4.2% (2) 3.8% (1) 0.50
Pregnancy-induced HTN 10.6% (5) 3.8% (1) 0.41
Pre-eclampsia 8.5% (4) 7.7% (2) 0.90
Gestational diabetes 10.6% (5) 3.8% (1) 0.41
PPROM 14.9% (7) 3.8% (1) 0.25
Neonatal complicationsd
SGAe 12.2% (5) 22.2% (2) 0.43
LBWf 22% (9) 33.3% (3) 0.67
NICU admission required 12.2% (5) 0 0.27
a

Defined as 0–1 dose of COVID 19 vaccine.

b

Defined as 2 or more doses of COVID 19 vaccine.

c

Of completed pregnancies.

d

Reported in terms of livebirths.

e

SGA defined as weight below the 10th percentile for gestation.

f

LBW defined as birthweight <2500 g.

HTN: hypertension; LBW: low birthweight; NICU: neonatal intensive care unit; PPROM: premature rupture of membranes; SGA: small for gestational age.